- Home
- SBLK vs RDY Comparison
SBLK vs RDY Comparison
Compare SBLK & RDY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SBLK
- RDY
- Stock Information
- Founded
- SBLK 2006
- RDY 1984
- Country
- SBLK Greece
- RDY India
- Employees
- SBLK N/A
- RDY N/A
- Industry
- SBLK Marine Transportation
- RDY Biotechnology: Pharmaceutical Preparations
- Sector
- SBLK Consumer Discretionary
- RDY Health Care
- Exchange
- SBLK Nasdaq
- RDY Nasdaq
- Market Cap
- SBLK 2.0B
- RDY 2.1B
- IPO Year
- SBLK N/A
- RDY N/A
- Fundamental
- Price
- SBLK $17.38
- RDY $14.77
- Analyst Decision
- SBLK Strong Buy
- RDY Strong Buy
- Analyst Count
- SBLK 3
- RDY 2
- Target Price
- SBLK $22.67
- RDY $16.95
- AVG Volume (30 Days)
- SBLK 2.0M
- RDY 1.5M
- Earning Date
- SBLK 08-06-2025
- RDY 07-28-2025
- Dividend Yield
- SBLK 1.15%
- RDY 0.55%
- EPS Growth
- SBLK N/A
- RDY 1.47
- EPS
- SBLK 1.96
- RDY 0.79
- Revenue
- SBLK $1,236,718,000.00
- RDY $3,809,801,863.00
- Revenue This Year
- SBLK N/A
- RDY $10.24
- Revenue Next Year
- SBLK $14.96
- RDY N/A
- P/E Ratio
- SBLK $9.09
- RDY $18.62
- Revenue Growth
- SBLK 25.60
- RDY 16.61
- 52 Week Low
- SBLK $12.06
- RDY $12.26
- 52 Week High
- SBLK $24.51
- RDY $16.89
- Technical
- Relative Strength Index (RSI)
- SBLK 57.58
- RDY 43.04
- Support Level
- SBLK $16.88
- RDY $14.81
- Resistance Level
- SBLK $18.59
- RDY $15.25
- Average True Range (ATR)
- SBLK 0.46
- RDY 0.20
- MACD
- SBLK 0.03
- RDY -0.11
- Stochastic Oscillator
- SBLK 53.57
- RDY 6.44
About SBLK Star Bulk Carriers Corp.
Star Bulk Carriers Corp provides seaborne transportation solutions in the dry bulk sector. The company owns and operates dry bulk carrier vessels, which are used to transport bulk, such as iron ore, coal, grains, bauxite, fertilizers, and steel products. It owns a fleet of vessels that consists of Newcastlemax, Capesize, Post Panamax, Kamsarmax, Panamax, Ultramax, and Supramax. It generates revenues through the voyages it carries out.
About RDY Dr. Reddy's Laboratories Ltd
Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly half of its generics sales, and it services India (about 20% of its generics sales), Russia (10%), and certain European and Latin American countries. Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.